Natriumklorid Fresenius Kabi 9 mg/ml infusjonsvæske clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedPhase II and Phase III (Integrated)
Effect of intravenous immunoglobulins on painful sensory neuropathy evaluated by aggregated N-of-one trials
This study is testing if a medicine called intravenous immunoglobulins (IVIG) can help reduce pain in people with nerve conditions that cause pain. We're comparing it to an inactive treatment (placebo) to see how well it works and if it's safe.
For: Idiopathic painful small fiber neuropathy or sensory neuronopathy.Norway - AuthorisedTherapeutic exploratory (Phase II)
A randomized, placebo-controlled, double-blind, 2-period cross-over study in youth with autism spectrum disorders evaluating social and repetitive behaviors after four weeks of twice daily-doses of 24IU of intranasally administered oxytocin
This study looks at how a nose spray with a substance called oxytocin might affect social skills and repetitive behaviours in young people with autism over four weeks. We want to see if it makes a difference.
For: Autism spectrum disorderNorway - AuthorisedTherapeutic exploratory (Phase II)
Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial
This study is looking into whether a nasal spray containing oxytocin can help people reduce their dependence on benzodiazepine medication more effectively than current methods. They're comparing it to regular dose reduction and a dummy spray, focusing on easing withdrawal symptoms.
For: Benzodiazepine dependence (F13.2)Norway